Read this company snapshot
Daily valuation snapshot
Quantum Biopharma Ltd. Class B Subordinate Voting Shares: source evidence dated 2026-10-09.
- Daily close (USD)
- $2.94
- Market capitalization (USD)
- $23,777,311.74
- Price / earnings (TTM)
- Not reported
- Price / book
- 4.66
The source values and product destination above identify the example to inspect.
What business is this, and what does its dated valuation mean?
Check the market day first. P/E uses trailing earnings; book value and market capitalization answer different questions.
Daily valuation dataset and column definitionsOpen the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research QNTM in the app
Open the company research view or ask Aurora to reconcile reporting periods, earnings, debt and the figures behind the valuation.
Research QNTM in the appKeep reporting dates and units beside the answer, and inspect its original citations.
Company overview
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments. The company researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. Its lead compound is Lucid-MS, a patented new chemical entity that is in Phase 2 clinical trial to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. It also develops FSD-PEA, which is in preparation for Phase 2 trial for the treatment of inflammatory diseases, such as mast cell activation syndrome; Lucid-PSYCH to treat major depressive disorder; and unbuzzd, a dietary supplement for the treatment of alcohol misuse. In addition, the company maintains a portfolio of strategic investments comprising loans secured by residential property. The company was formerly known as FSD Pharma Inc. and changed its name to Quantum BioPharma Ltd., in August 2024. Quantum BioPharma Ltd. was founded in 1998 and is headquartered in Toronto, Canada.
Daily valuation snapshot
See the complete daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-09. TTM means trailing twelve months. Use the market date when comparing QNTM with another company.
Scroll sideways to compare all columns. Select a heading to sort.
| Daily close (USD) | $2.94 |
| Market capitalization (USD) | $23,777,311.74 |
| Price / earnings (TTM) | Not reported |
| Price / book | 4.66 |
No matching rows. Clear the filter to see all records.
Read QNTM's valuation metrics
Company size
Quantum Biopharma Ltd. Class B Subordinate Voting Shares's recorded market capitalization is $23,777,311.74. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
QNTM's recorded price-to-book ratio is 4.66. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Quantum Biopharma Ltd. Class B Subordinate Voting Shares with Aurora
Use the snapshot above to ask a specific question about QNTM. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow QNTM's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.